 | • レポートコード：MRC2-11QY01556 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫抑制薬のグローバル市場について調査・分析したレポートです。種類別（カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体）市場規模、用途別（腎臓、骨髄、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫抑制薬の競争状況、市場シェア ・世界の免疫抑制薬市場：種類別市場規模 2015年-2020年（カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体） ・世界の免疫抑制薬市場：種類別市場規模予測 2021年-2026年（カルシニューリン阻害剤、MTOR阻害剤、抗増殖剤、ステロイド、抗体） ・世界の免疫抑制薬市場：用途別市場規模 2015年-2020年（腎臓、骨髄、その他） ・世界の免疫抑制薬市場：用途別市場規模予測 2021年-2026年（腎臓、骨髄、その他） ・北米の免疫抑制薬市場分析：米国、カナダ ・ヨーロッパの免疫抑制薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫抑制薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫抑制薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫抑制薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Astellas Pharma、Roche、Pfizer、Sanofi、Allergan、Bristol-Myers Squibb、AbbVie、Veloxis Pharmaceuticals、GSK ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Immunosuppressant Drugs Market
The global Immunosuppressant Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Immunosuppressant Drugs Scope and Market Size
Immunosuppressant Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunosuppressant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Immunosuppressant Drugs market is segmented into
Calcineurin Inhibitors
MTOR Inhibitors
Anti-proliferative Agents
Steroids
Antibodies
Segment by Application, the Immunosuppressant Drugs market is segmented into
Kidney
Bone Marrow
Others
Regional and Country-level Analysis
The Immunosuppressant Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunosuppressant Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunosuppressant Drugs Market Share Analysis
Immunosuppressant Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunosuppressant Drugs business, the date to enter into the Immunosuppressant Drugs market, Immunosuppressant Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Astellas Pharma
Roche
Pfizer
Sanofi
Allergan
Bristol-Myers Squibb
AbbVie
Veloxis Pharmaceuticals
GSK
1 Study Coverage
1.1 Immunosuppressant Drugs Product Introduction
1.2 Market Segments
1.3 Key Immunosuppressant Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunosuppressant Drugs Market Size Growth Rate by Type
1.4.2 Calcineurin Inhibitors
1.4.3 MTOR Inhibitors
1.4.4 Anti-proliferative Agents
1.4.5 Steroids
1.4.6 Antibodies
1.5 Market by Application
1.5.1 Global Immunosuppressant Drugs Market Size Growth Rate by Application
1.5.2 Kidney
1.5.3 Bone Marrow
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunosuppressant Drugs Market Size, Estimates and Forecasts
2.1.1 Global Immunosuppressant Drugs Revenue 2015-2026
2.1.2 Global Immunosuppressant Drugs Sales 2015-2026
2.2 Global Immunosuppressant Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immunosuppressant Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immunosuppressant Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immunosuppressant Drugs Competitor Landscape by Players
3.1 Immunosuppressant Drugs Sales by Manufacturers
3.1.1 Immunosuppressant Drugs Sales by Manufacturers (2015-2020)
3.1.2 Immunosuppressant Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Immunosuppressant Drugs Revenue by Manufacturers
3.2.1 Immunosuppressant Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Immunosuppressant Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunosuppressant Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunosuppressant Drugs Revenue in 2019
3.2.5 Global Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immunosuppressant Drugs Price by Manufacturers
3.4 Immunosuppressant Drugs Manufacturing Base Distribution, Product Types
3.4.1 Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunosuppressant Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Immunosuppressant Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunosuppressant Drugs Market Size by Type (2015-2020)
4.1.1 Global Immunosuppressant Drugs Sales by Type (2015-2020)
4.1.2 Global Immunosuppressant Drugs Revenue by Type (2015-2020)
4.1.3 Immunosuppressant Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunosuppressant Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunosuppressant Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Immunosuppressant Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Immunosuppressant Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunosuppressant Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunosuppressant Drugs Market Size by Application (2015-2020)
5.1.1 Global Immunosuppressant Drugs Sales by Application (2015-2020)
5.1.2 Global Immunosuppressant Drugs Revenue by Application (2015-2020)
5.1.3 Immunosuppressant Drugs Price by Application (2015-2020)
5.2 Immunosuppressant Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunosuppressant Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Immunosuppressant Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunosuppressant Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Immunosuppressant Drugs by Country
6.1.1 North America Immunosuppressant Drugs Sales by Country
6.1.2 North America Immunosuppressant Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immunosuppressant Drugs Market Facts & Figures by Type
6.3 North America Immunosuppressant Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Immunosuppressant Drugs by Country
7.1.1 Europe Immunosuppressant Drugs Sales by Country
7.1.2 Europe Immunosuppressant Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunosuppressant Drugs Market Facts & Figures by Type
7.3 Europe Immunosuppressant Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Immunosuppressant Drugs by Region
8.1.1 Asia Pacific Immunosuppressant Drugs Sales by Region
8.1.2 Asia Pacific Immunosuppressant Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immunosuppressant Drugs Market Facts & Figures by Type
8.3 Asia Pacific Immunosuppressant Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Immunosuppressant Drugs by Country
9.1.1 Latin America Immunosuppressant Drugs Sales by Country
9.1.2 Latin America Immunosuppressant Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immunosuppressant Drugs Market Facts & Figures by Type
9.3 Central & South America Immunosuppressant Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Immunosuppressant Drugs by Country
10.1.1 Middle East and Africa Immunosuppressant Drugs Sales by Country
10.1.2 Middle East and Africa Immunosuppressant Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immunosuppressant Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Immunosuppressant Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Immunosuppressant Drugs Products Offered
11.1.5 Novartis Related Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Description and Business Overview
11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Immunosuppressant Drugs Products Offered
11.2.5 Astellas Pharma Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Immunosuppressant Drugs Products Offered
11.3.5 Roche Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Immunosuppressant Drugs Products Offered
11.4.5 Pfizer Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Immunosuppressant Drugs Products Offered
11.5.5 Sanofi Related Developments
11.6 Allergan
11.6.1 Allergan Corporation Information
11.6.2 Allergan Description and Business Overview
11.6.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Allergan Immunosuppressant Drugs Products Offered
11.6.5 Allergan Related Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description and Business Overview
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Immunosuppressant Drugs Products Offered
11.7.5 Bristol-Myers Squibb Related Developments
11.8 AbbVie
11.8.1 AbbVie Corporation Information
11.8.2 AbbVie Description and Business Overview
11.8.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AbbVie Immunosuppressant Drugs Products Offered
11.8.5 AbbVie Related Developments
11.9 Veloxis Pharmaceuticals
11.9.1 Veloxis Pharmaceuticals Corporation Information
11.9.2 Veloxis Pharmaceuticals Description and Business Overview
11.9.3 Veloxis Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Veloxis Pharmaceuticals Immunosuppressant Drugs Products Offered
11.9.5 Veloxis Pharmaceuticals Related Developments
11.10 GSK
11.10.1 GSK Corporation Information
11.10.2 GSK Description and Business Overview
11.10.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.10.4 GSK Immunosuppressant Drugs Products Offered
11.10.5 GSK Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Immunosuppressant Drugs Products Offered
11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immunosuppressant Drugs Market Estimates and Projections by Region
12.1.1 Global Immunosuppressant Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Immunosuppressant Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Immunosuppressant Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Immunosuppressant Drugs Sales Forecast (2021-2026)
12.2.2 North America: Immunosuppressant Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Immunosuppressant Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Immunosuppressant Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Immunosuppressant Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Immunosuppressant Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Immunosuppressant Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immunosuppressant Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immunosuppressant Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immunosuppressant Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immunosuppressant Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Immunosuppressant Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Immunosuppressant Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Immunosuppressant Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Immunosuppressant Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immunosuppressant Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immunosuppressant Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immunosuppressant Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immunosuppressant Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunosuppressant Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunosuppressant Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Immunosuppressant Drugs Market Segments
Table 2. Ranking of Global Top Immunosuppressant Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Immunosuppressant Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Calcineurin Inhibitors
Table 5. Major Manufacturers of MTOR Inhibitors
Table 6. Major Manufacturers of Anti-proliferative Agents
Table 7. Major Manufacturers of Steroids
Table 8. Major Manufacturers of Antibodies
Table 9. Global Immunosuppressant Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Immunosuppressant Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Immunosuppressant Drugs Sales by Regions 2015-2020 (K MT)
Table 12. Global Immunosuppressant Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Immunosuppressant Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Immunosuppressant Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Immunosuppressant Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Immunosuppressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunosuppressant Drugs as of 2019)
Table 18. Immunosuppressant Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Immunosuppressant Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Immunosuppressant Drugs Price (2015-2020) (USD/MT)
Table 21. Immunosuppressant Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Immunosuppressant Drugs Product Type
Table 23. Date of International Manufacturers Enter into Immunosuppressant Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunosuppressant Drugs Sales by Type (2015-2020) (K MT)
Table 26. Global Immunosuppressant Drugs Sales Share by Type (2015-2020)
Table 27. Global Immunosuppressant Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Immunosuppressant Drugs Revenue Share by Type (2015-2020)
Table 29. Immunosuppressant Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Immunosuppressant Drugs Sales by Application (2015-2020) (K MT)
Table 31. Global Immunosuppressant Drugs Sales Share by Application (2015-2020)
Table 32. North America Immunosuppressant Drugs Sales by Country (2015-2020) (K MT)
Table 33. North America Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Immunosuppressant Drugs Sales by Type (2015-2020) (K MT)
Table 37. North America Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Immunosuppressant Drugs Sales by Application (2015-2020) (K MT)
Table 39. North America Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Immunosuppressant Drugs Sales by Country (2015-2020) (K MT)
Table 41. Europe Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Immunosuppressant Drugs Sales by Type (2015-2020) (K MT)
Table 45. Europe Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Immunosuppressant Drugs Sales by Application (2015-2020) (K MT)
Table 47. Europe Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Immunosuppressant Drugs Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific Immunosuppressant Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Immunosuppressant Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Immunosuppressant Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Immunosuppressant Drugs Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Immunosuppressant Drugs Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Immunosuppressant Drugs Sales by Country (2015-2020) (K MT)
Table 57. Latin America Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Immunosuppressant Drugs Sales by Type (2015-2020) (K MT)
Table 61. Latin America Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Immunosuppressant Drugs Sales by Application (2015-2020) (K MT)
Table 63. Latin America Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Immunosuppressant Drugs Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa Immunosuppressant Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Immunosuppressant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Immunosuppressant Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Immunosuppressant Drugs Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Immunosuppressant Drugs Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Table 72. Novartis Corporation Information
Table 73. Novartis Description and Major Businesses
Table 74. Novartis Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Novartis Product
Table 76. Novartis Recent Development
Table 77. Astellas Pharma Corporation Information
Table 78. Astellas Pharma Description and Major Businesses
Table 79. Astellas Pharma Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Astellas Pharma Product
Table 81. Astellas Pharma Recent Development
Table 82. Roche Corporation Information
Table 83. Roche Description and Major Businesses
Table 84. Roche Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Roche Product
Table 86. Roche Recent Development
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Major Businesses
Table 89. Pfizer Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Pfizer Product
Table 91. Pfizer Recent Development
Table 92. Sanofi Corporation Information
Table 93. Sanofi Description and Major Businesses
Table 94. Sanofi Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Sanofi Product
Table 96. Sanofi Recent Development
Table 97. Allergan Corporation Information
Table 98. Allergan Description and Major Businesses
Table 99. Allergan Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Allergan Product
Table 101. Allergan Recent Development
Table 102. Bristol-Myers Squibb Corporation Information
Table 103. Bristol-Myers Squibb Description and Major Businesses
Table 104. Bristol-Myers Squibb Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Bristol-Myers Squibb Product
Table 106. Bristol-Myers Squibb Recent Development
Table 107. AbbVie Corporation Information
Table 108. AbbVie Description and Major Businesses
Table 109. AbbVie Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. AbbVie Product
Table 111. AbbVie Recent Development
Table 112. Veloxis Pharmaceuticals Corporation Information
Table 113. Veloxis Pharmaceuticals Description and Major Businesses
Table 114. Veloxis Pharmaceuticals Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Veloxis Pharmaceuticals Product
Table 116. Veloxis Pharmaceuticals Recent Development
Table 117. GSK Corporation Information
Table 118. GSK Description and Major Businesses
Table 119. GSK Immunosuppressant Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. GSK Product
Table 121. GSK Recent Development
Table 122. Global Immunosuppressant Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 123. Global Immunosuppressant Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Immunosuppressant Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Immunosuppressant Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Immunosuppressant Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 127. North America: Immunosuppressant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Immunosuppressant Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 129. Europe: Immunosuppressant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Immunosuppressant Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 131. Asia Pacific: Immunosuppressant Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Immunosuppressant Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 133. Latin America: Immunosuppressant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Immunosuppressant Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 135. Middle East and Africa: Immunosuppressant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Immunosuppressant Drugs Players
Table 140. Immunosuppressant Drugs Customers List
Table 141. Immunosuppressant Drugs Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunosuppressant Drugs Product Picture
Figure 2. Global Immunosuppressant Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Calcineurin Inhibitors Product Picture
Figure 4. MTOR Inhibitors Product Picture
Figure 5. Anti-proliferative Agents Product Picture
Figure 6. Steroids Product Picture
Figure 7. Antibodies Product Picture
Figure 8. Global Immunosuppressant Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Kidney
Figure 10. Bone Marrow
Figure 11. Others
Figure 12. Immunosuppressant Drugs Report Years Considered
Figure 13. Global Immunosuppressant Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Immunosuppressant Drugs Sales 2015-2026 (K MT)
Figure 15. Global Immunosuppressant Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Immunosuppressant Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Immunosuppressant Drugs Sales Market Share by Region in 2019
Figure 18. Global Immunosuppressant Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Immunosuppressant Drugs Revenue Market Share by Region in 2019
Figure 20. Global Immunosuppressant Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Immunosuppressant Drugs Revenue in 2019
Figure 22. Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Immunosuppressant Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Immunosuppressant Drugs Sales Market Share by Type in 2019
Figure 25. Global Immunosuppressant Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Immunosuppressant Drugs Revenue Market Share by Type in 2019
Figure 27. Global Immunosuppressant Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Immunosuppressant Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Immunosuppressant Drugs Sales Market Share by Application in 2019
Figure 30. Global Immunosuppressant Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Immunosuppressant Drugs Revenue Market Share by Application in 2019
Figure 32. North America Immunosuppressant Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Immunosuppressant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Immunosuppressant Drugs Sales Market Share by Country in 2019
Figure 35. North America Immunosuppressant Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Immunosuppressant Drugs Market Share by Type in 2019
Figure 41. North America Immunosuppressant Drugs Market Share by Application in 2019
Figure 42. Europe Immunosuppressant Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Immunosuppressant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Immunosuppressant Drugs Sales Market Share by Country in 2019
Figure 45. Europe Immunosuppressant Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Immunosuppressant Drugs Market Share by Type in 2019
Figure 57. Europe Immunosuppressant Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Immunosuppressant Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Immunosuppressant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Immunosuppressant Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Immunosuppressant Drugs Revenue Market Share by Region in 2019
Figure 62. China Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Immunosuppressant Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Immunosuppressant Drugs Market Share by Application in 2019
Figure 86. Latin America Immunosuppressant Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Immunosuppressant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Immunosuppressant Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Immunosuppressant Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Immunosuppressant Drugs Market Share by Type in 2019
Figure 97. Latin America Immunosuppressant Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Immunosuppressant Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Immunosuppressant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Immunosuppressant Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Immunosuppressant Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Immunosuppressant Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Immunosuppressant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Immunosuppressant Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Immunosuppressant Drugs Market Share by Application in 2019
Figure 110. North America Immunosuppressant Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Immunosuppressant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Immunosuppressant Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Immunosuppressant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Immunosuppressant Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Immunosuppressant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Immunosuppressant Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Immunosuppressant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Immunosuppressant Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Immunosuppressant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
重症筋無力症治療薬の世界市場（～2026年） Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and …- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗レトロウイルス薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-Retroviral Drugs Market The global Anti-Retroviral Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-Retroviral Drugs Scope and Market Size Anti-Retroviral Drugs marke…
- バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…
- 腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…